2021 Office Holiday Closure

Please note that the HREBA office will close for the winter holidays on December 24, 2021 and will re-open on January 4, 2022.

If you have a question, please email the appropriate committee at the following address. These emails will be monitored during the closure:

Cancer Committee: cancer@hreba.ca

Clinical Trials Committee: clinicaltrials@hreba.ca

Community Health Committee: communityhealth@hreba.ca

For urgent requests only, the emergency line is 780-999-6792.

2020 Office Holiday Closure

Please note that the HREBA office will close for the winter holidays on December 24, 2020 and will re-open on January 4, 2021.

For urgent requests only, the after hours emergency line is 780-999-6792.

Guidance during COVID-19 Outbreak

In light of the COVID 19 outbreak, the Alberta REB’s advise investigators to consider if their research protocols could be modified or delayed, to limit personal contacts, laboratory visits or trips into clinics and hospitals. Specifically, in some research settings in-person participant interactions could be reduced and/or replaced with telephone or online communication. Considerations include the nature of your protocol, the type of participants engaged in the research, and any additional risk that may arise by switching from in-person to virtual communication.  Revised participant consents or consent addendums may be required (e.g., to update privacy considerations with use of different communication channels).  Where research staff are feeling unwell, care should be taken to stay home to prevent transmission of any illness.  If COVID 19 is known or suspected, AHS protocols should be followed (https://www.albertahealthservices.ca/topics/Page16944.aspx)

While TCPS 2 typically requires review and approval of modifications prior to implementation, an exception can be made where the change is necessary to eliminate an immediate risk to participant(s) (Article 6.15).  Such changes may be implemented but must be reported to the REB at the earliest opportunity (within 5 business days as a guide).  The REBs will work to expedite these requests to minimize research disruption.

A reminder that where the research involves physical assessments and use of equipment (e.g., metabolic carts, facemasks, mouthpieces, noseclips, straps, turbines, valves, tubing, cannula, treadmills, etc.) disinfection according to manufacturer’s standards where applicable is paramount and use of single use accessories is advisable.  In the absence of manufacturers standards, thorough cleaning between participants is advised.

Please see Health Canada’s website for up-to-date information:


HREBA notes that much of the research in Alberta takes place in the community settings. In addition to the above guidance: Research taking place in a community clinic or private setting should consider different scenarios should staff become ill and research activities must continue for the safety of the participants. It is advised these centres collaborate with neighbouring researchers and develop a continuance plan to ensure safe research practices. We will provide updates as available, if you need additional information please email info@hreba.ca or call 780-999-6792.

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic: Click here

Health Canada Guidance on Management of Clinical Trials during the COVID-19 Pandemic:  Click here

2019 Office Holiday Closure

Please note that the HREBA office will close for the winter holidays on December 25, 2019 and will re-open on January 2, 2020.

For urgent requests only, the after hours emergency line is 780-999-6792.

Updated HREBA-CTC Guidances

Updated guidances have been posted for the submission of:

Note that, beginning with studies expiring in January 2020, study expiry dates will likely no longer correspond to CTC meeting dates. As renewals must be reviewed at the CTC meeting scheduled prior to/on the study expiry date, please ensure they are submitted no later than one week before the applicable meeting.

Board of Record Agreement

As of August 1, 2019, investigators submitting to any of the Health Research Ethics Board of Alberta (HREBA) committees will be required to have an official agreement appointing HREBA as their Board of Record. For investigators conducting research through private practice or other community-based organizations (both for and not-for profit), a signed Board of Record Agreement will be required.

Read more…

U.S. Common Rule Update

On January 21, 2019, the 2018 revision of the Federal Policy for the Protection of Human Subjects (aka the “Common Rule”, found in 45 CFR 46) was implemented. Research that is sponsored or monitored by the United States Department of Health and Human Services (US DHHS – NIH, NCI, OHRP) is subject to this revised regulation, within the confines of existing Canadian regulations and laws.

Read More…

Office Holiday Closure

Please note that the office will be closed due to the winter holidays as follows:

  • Monday December 24th to Wednesday December 26th, 2018
  • Tuesday January 1st, 2018

For urgent requests only, the after hours emergency line is 780-999-6792.

Expanded External View Access to the IRISS System

Effective October 29, 2018 the Health Research Ethics Board of Alberta (HREBA) will be enabling improved view access to cancer studies in the IRISS system for research administration personnel at the Northern Alberta Clinical Trials and Research Centre (NACTRC). NACTRC is a joint venture between the University of Alberta and Alberta Health Services and provides administrative and operational services for research involving Alberta Health Services in the greater Edmonton area.

View access for NACTRC will be enabled according to information provided by researchers within the HREBA – Cancer Committee applications on a study by study basis.

Read More…